alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Barry E. Greene
President and Chief Operating Officer, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 42 board members in 3 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Barry E. Greene has been the President and Chief Operating Officer at Alnylam Pharmaceuticals, Inc. since December 12, 2007 and October 2003 respectively. Mr. Greene has more than 20 years of experience in the healthcare, pharmaceutical and biotechnology industries. Mr. Greene joined Alnylam in 2003 and has over 15 years of experience in the healthcare industry. He served as the Principal Financial Officer and Principal Accounting Officer of Alnylam Pharmaceuticals ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*
Director, Chairman of Ad Hoc Business Development Committee and Member of Compensation Committee
Former Director and Member of Nominating & Corporate Governance Committee
Director, Chairman of Compensation Committee and Member of Audit Committee
University of Pittsburgh
|Stanley T. Crooke M.D., Ph.D.||Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee|
Isis Pharmaceuticals, Inc.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|